Road to Victories

Keith Weston Patient Friend

Keith first saw the impact the MMRF has on patients and their families while spectating at Ironman Lake Placid in 2015.He helped his son fundraise in following years, and then regained his love of cycling while following the R2V Cross Country Riders. He began to train and joined them on the final leg of their ride.This year, Keith looks to take on a bigger challenge and increase his impact as a member of the team riding from Vermont to Canada.”I’m looking forward to a once in a lifetime ride, while helping an amazing charity”

Riding to honor cancer patients

Keith Weston

Training for this event is tough, but nothing compared to fighting cancer! As we climb the highest hills of Vermont, I will be holding those dear to me that have…

09/14/2019

The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

Sponsored by

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More